104 related articles for article (PubMed ID: 34522218)
1. A tumor microenvironment responsive nanosystem for chemodynamic/chemical synergistic theranostics of colorectal cancer.
Wang L; Xia J; Fan H; Hou M; Wang H; Wang X; Zhang K; Cao L; Liu X; Ling J; Yu H; Wu X; Sun J
Theranostics; 2021; 11(18):8909-8925. PubMed ID: 34522218
[No Abstract] [Full Text] [Related]
2. Designing multifunctional cancer-targeted nanosystem for magnetic resonance molecular imaging-guided theranostics of lung cancer.
Gao P; Mei C; He L; Xiao Z; Chan L; Zhang D; Shi C; Chen T; Luo L
Drug Deliv; 2018 Nov; 25(1):1811-1825. PubMed ID: 30465437
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin-activated and hemoglobin-mediated injectable hydrogel system for antitumor chemodynamic and chemotherapy.
Tsen HT; Sun TC; Lai TK; Huang WY; Wang HC; Lu TT; Wang TW
Biomed Pharmacother; 2024 Jun; 175():116713. PubMed ID: 38735083
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive ROS imaging and drug delivery monitoring in the tumor microenvironment.
Jung W; Asaduddin M; Yoo D; Lee DY; Son Y; Kim D; Keum H; Lee J; Park SH; Jon S
Biomaterials; 2024 Oct; 310():122633. PubMed ID: 38810387
[TBL] [Abstract][Full Text] [Related]
5. Biodegradable manganese engineered nanocapsules for tumor-sensitive near-infrared persistent luminescence/magnetic resonance imaging and simultaneous chemotherapy.
Zou R; Li J; Yang T; Zhang Y; Jiao J; Wong KL; Wang J
Theranostics; 2021; 11(17):8448-8463. PubMed ID: 34373752
[No Abstract] [Full Text] [Related]
6. Therapeutic potentials of FexMoyS-PEG nanoparticles in colorectal cancer: a multimodal approach via ROS-ferroptosis-glycolysis regulation.
Yu Z; Wang C; Ye Y; Wang S; Jiang K
J Nanobiotechnology; 2024 May; 22(1):253. PubMed ID: 38755600
[TBL] [Abstract][Full Text] [Related]
7. Fe-based cyclically catalyzing double free radical nanogenerator for tumor-targeted chemodynamic therapy.
Wang Y; Zhu C; Fan X; Yang Y; Chen Z; Yu L; Zhang Y
J Mater Chem B; 2024 May; 12(20):4922-4934. PubMed ID: 38683028
[TBL] [Abstract][Full Text] [Related]
8. ROS-driven supramolecular nanoparticles exhibiting efficient drug delivery for chemo/Chemodynamic combination therapy for Cancer treatment.
Chen H; Xing C; Lei H; Yan B; Zhang H; Tong T; Guan Y; Kang Y; Pang J
J Control Release; 2024 Apr; 368():637-649. PubMed ID: 38484895
[TBL] [Abstract][Full Text] [Related]
9. Tumor pH-responsive metastable-phase manganese sulfide nanotheranostics for traceable hydrogen sulfide gas therapy primed chemodynamic therapy.
He T; Qin X; Jiang C; Jiang D; Lei S; Lin J; Zhu WG; Qu J; Huang P
Theranostics; 2020; 10(6):2453-2462. PubMed ID: 32194812
[TBL] [Abstract][Full Text] [Related]
10. Macrophage membrane-camouflaged nanoclusters of ultrasmall iron oxide nanoparticles for precision glioma theranostics.
Zhang B; Yang R; Yu H; Peng Y; Huang H; Hameed MMA; Wang H; Zhang G; El-Newehy M; Shen M; Shi X; Peng S
Biomater Sci; 2024 May; 12(10):2705-2716. PubMed ID: 38607326
[TBL] [Abstract][Full Text] [Related]
11. Chemodynamic nanomaterials for cancer theranostics.
Xin J; Deng C; Aras O; Zhou M; Wu C; An F
J Nanobiotechnology; 2021 Jun; 19(1):192. PubMed ID: 34183023
[TBL] [Abstract][Full Text] [Related]
12. Glutathione and acid dual-responsive bismuth-based nanosensitizer for chemo-mediated cancer sonodynamic therapy.
Chen G; Ping J; Du J; Zhao L; Li Y; Liu H
Biomed Mater; 2024 Jun; 19(4):. PubMed ID: 38857606
[TBL] [Abstract][Full Text] [Related]
13. Tumor Microenvironment-Activated Nanostructure to Enhance MRI Capability and Nanozyme Activity for Highly Tumor-Specific Multimodal Theranostics.
Xie W; Gan Y; Wang L; Si Y; Li Q; Song T; Wei P; Wu Z; Zhang G
Small; 2024 Apr; 20(14):e2306446. PubMed ID: 38105592
[TBL] [Abstract][Full Text] [Related]
14. Intracellular Criegee's mechanism-based synergistic ozone therapy mediated by oleogels for cancer treatment.
Lu J; Zheng R; Shi Z; Gao X; Li Y; Fahad A; Ufurahi-Pambe N; Jin Z; Chen S; Xie W; Guo Z; Yu J; Che S; Zhang G; Xu B; Wei Y; Zhao L
J Control Release; 2024 Jun; 370():879-890. PubMed ID: 38782060
[TBL] [Abstract][Full Text] [Related]
15. A mesoporous superparamagnetic iron oxide nanoparticle as a generic drug delivery system for tumor ferroptosis therapy.
Yang J; Xiong W; Huang L; Li Z; Fan Q; Hu F; Duan X; Fan J; Li B; Feng J; Xu Y; Chen X; Shen Z
J Nanobiotechnology; 2024 Apr; 22(1):204. PubMed ID: 38658948
[TBL] [Abstract][Full Text] [Related]
16. Dual drug-loaded metal-phenolic networks for targeted magnetic resonance imaging and synergistic chemo-chemodynamic therapy of breast cancer.
Xia L; Ni C; Sun H; Guo H; Huang H; Cao X; Xia J; Shi X; Guo R
J Mater Chem B; 2024 Jun; ():. PubMed ID: 38867551
[TBL] [Abstract][Full Text] [Related]
17. Manganese-derived biomaterials for tumor diagnosis and therapy.
Huang P; Tang Q; Li M; Yang Q; Zhang Y; Lei L; Li S
J Nanobiotechnology; 2024 Jun; 22(1):335. PubMed ID: 38879519
[TBL] [Abstract][Full Text] [Related]
18. Achieving Complete Tumor Clearance: A Minimalist Manganese Hydrogel for Magnetic Resonance Imaging-Guided Synergetic Microwave Ablation and Chemodynamic Therapy.
Zhou Y; Shu G; Luo Y; Wang F; Jing X; Pan J; Sun SK
Adv Healthc Mater; 2024 Apr; 13(9):e2303268. PubMed ID: 38140916
[TBL] [Abstract][Full Text] [Related]
19. A tumor multicomponent targeting chemoimmune drug delivery system for reprograming the tumor microenvironment and personalized cancer therapy.
Sau S; Tatiparti K; Alsaab HO; Kashaw SK; Iyer AK
Drug Discov Today; 2018 Jul; 23(7):1344-1356. PubMed ID: 29551455
[TBL] [Abstract][Full Text] [Related]
20. Tumor Microenvironment-Activatable Nanosystem Capable of Overcoming Multiple Therapeutic Obstacles for Augmenting Immuno/Metal-Ion Therapy.
Cheng Q; Shi X; Chen Y; Li Q; Wang J; Li H; Wang L; Wang Z
ACS Nano; 2024 Mar; 18(12):8996-9010. PubMed ID: 38477219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
